The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Folic Acid-Conjugated Chitosan Nanoparticles Enhanced Protoporphyrin IX Accumulation in Colorectal Cancer Cells
Abstract
Folic acid can be covalently conjugated to chitosan molecules via its gamma-carboxyl moiety and thus retain a high affinity for colorectal cancer cells bearing folate receptor overexpression. Colorectal cancer is one of the leading causes of malignant death and often goes undetected with current colonoscopy practices. Improved methods of detecting dysplasia and tumors during colonoscopy will improve mortality. A folic acid conjugated chitosan nanoparticle as a suitable vehicle for carrying 5-aminolaevulinic acid (5-ALA) is developed to enhance the detection of colorectal cancer cells in vivo after a short-term uptake period. Chitosan can be successfully conjugated with folic acid to produce folic acid-chitosan conjugate, which is then loaded with 5-ALA to create nanoparticles (fCNA). The loading efficiency of 5-ALA in fCNA particles and the z-average diameter were in the range 35-40% and 100 nm, respectively. The zeta-potential for fCNA was 20 mV, enough to keep the nanoparticle stable without aggregation. The fCNA is then incubated with HT29 and Caco-2 colorectal cancer cell lines overexpressing folate receptor on the surface of the cell membrane to determine the rate of accumulation of protoporphyrin IX (PpIX). The results show that fCNA can be taken up more easily by HT29 and Caco-2 cell lines after short-term uptake period, most likely via receptor-mediated endocytosis, and the PpIX accumulates in cancer cells as a function of the folate receptor expression and the folic…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nanoparticles were taken up by HT-29 and Caco-2 cell lines after short-term of uptake period and the drug accumulated in cancer cells as a result of the folate receptor as well as the folic acid modification.”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [209]
Citations
Cites
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509
Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles
Yang, S.-J., Shieh, M.-J., Lin, F.-H., Lou, P.-J., Peng, C.-L., Wei, M.-F., Yao, C.-J., Lai, P.-S., & Young, T.-H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.014 · Cited by 56
Self-citation
Research works printed but not linked: 33
- Park E. K., 2005, Biomaterials, 26, 1053, 10.1016/j.biomaterials.2004.04.008 · DOI
- Chan P., 2007, Biomaterials, 28, 540, 10.1016/j.biomaterials.2006.08.046 · DOI
- Wang S., 1998, J. Controlled Release, 53, 39, 10.1016/S0168-3659(97)00236-8 · DOI
- Quintana A., 2002, Pharm. Res., 19, 1310, 10.1023/A:1020398624602 · DOI
- Oyewumi M. O., 2004, J. Controlled Release, 95, 613, 10.1016/j.jconrel.2004.01.002 · DOI
- Mansouri S., 2006, Biomaterials, 27, 2060, 10.1016/j.biomaterials.2005.09.020 · DOI
- Dubé D., 2002, Bioconjugate Chem., 13, 6856, 10.1021/bc010084g · DOI
- Liu S. Q., 2007, Biomaterials, 28, 1423, 10.1016/j.biomaterials.2006.11.013 · DOI
- Zhang Y., 2002, Biomaterials, 23, 1553, 10.1016/S0142-9612(01)00267-8 · DOI
- Rembacken B., 2001, Best Pract. Res. Clin. Gastroenterol., 15, 317, 10.1053/bega.2000.0176 · DOI
- Mountney L., Health Care Needs Assessment
- Allison R. R., 2004, Photodiagnosis Photodyn. Ther., 1, 263, 10.1016/S1572-1000(04)00084-5 · DOI
- Allison R. R., 2005, Photodiagnosis Photodyn. Ther., 2, 51, 10.1016/S1572-1000(05)00033-5 · DOI
- Pottier R. H., 1986, Photochem. Photobiol., 44, 679, 10.1111/j.1751-1097.1986.tb04726.x · DOI
- Grimbergen M. C., 2003, Eur. Urol., 44, 51, 10.1016/S0302-2838(03)00210-0 · DOI
- Steluti R., 2005, Eur. J. Pharm. Biopharm., 60, 439, 10.1016/j.ejpb.2005.01.011 · DOI
- Gederaas O. A., 1999, J. Photochem. Photobiol. B, 49, 162, 10.1016/S1011-1344(99)00051-2 · DOI
- Berscht P. C., 1994, Biomaterials, 15, 593, 10.1016/0142-9612(94)90209-7 · DOI
- Thanou M., 2001, Adv. Drug. Delivery Rev., 50, S91, 10.1016/S0169-409X(01)00180-6 · DOI
- Thanou M., 2001, Adv. Drug. Delivery Rev., 52, 117, 10.1016/S0169-409X(01)00231-9 · DOI
- Agnihotri S. A., 2004, J. Controlled Release, 100, 5, 10.1016/j.jconrel.2004.08.010 · DOI
- Qi L., 2004, Carbohydr. Res., 339, 2693, 10.1016/j.carres.2004.09.007 · DOI
- Du J., 2005, J. Biomed. Mater. Res. Part B, 72, 299, 10.1002/jbm.b.30156 · DOI
- Xu Y., 2003, Biomaterials, 24, 5015, 10.1016/S0142-9612(03)00408-3 · DOI
- Kiang T., 2004, Biomaterials, 25, 5293, 10.1016/j.biomaterials.2003.12.036 · DOI
- Gan Q., 2005, Colloid Surf., B, 44, 65, 10.1016/j.colsurfb.2005.06.001 · DOI
- Choy J. H., 2004, Biomaterials, 25, 3059, 10.1016/j.biomaterials.2003.09.083 · DOI
- Akasaka K., 2005, Chirality, 17, 544, 10.1002/chir.20203 · DOI
- Yang J. M., 2005, J. Membr. Sci., 258, 97, 10.1016/j.memsci.2005.02.033 · DOI
- Wang S., 1997, Bioconjugate Chem., 8, 673, 10.1021/bc9701297 · DOI
- Dawson, R. M. C., Elliott, D. C., Elliott, W. H., and Jones, K. M. (1986) Data for Biochemical Research, pp134−135,Oxford University Press,New York.
- Qi L., 2005, Bioorg. Med. Chem. Lett., 15, 1397, 10.1016/j.bmcl.2005.01.010 · DOI
- Hu Y., 2002, Biomaterials, 23, 3193, 10.1016/S0142-9612(02)00071-6 · DOI
Cited by
Sorted by citations
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
Moysan, E., Bastiat, G., & Benoit, J.-P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300370t · Cited by 225
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Narayan, R., Gadag, S., Cheruku, S. P., Raichur, A. M., Day, C. M., Garg, S., Manandhar, S., Pai, K. S. R., Suresh, A., Mehta, C. H., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117893 · Cited by 103
Metadata
- Authors
- Yang, S.-J., Lin, F.-H., Tsai, K.-C., Wei, M.-F., Tsai, H.-M., Wong, J.-M., & Shieh, M.-J.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-03-11
- Volume
- 21
- Issue
- 4
- Pages
- 679-689
- ISSN
- 1043-1802
- 1520-4812
- Cited by
- 272
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review